02/04/2016 - 12:55pm

Camber has launched its generic of Pfizer’s high blood pressure and chest pain treatment Corgard. 

02/03/2016 - 3:05pm

The company, alongside the launch of the drug, is offering a savings program for patients, which it said would reduce co-payments to $10 for the drug.

02/02/2016 - 3:17pm

Generic Pharmaceutical Association president and CEO Chip Davis issued a statement following the organization’s presentation to members of Congress about the savings attributed to generics. 

02/02/2016 - 11:20am

The drug, which had annual sales of about $714 million in 2015, is indicated to treat high cholesterol. 

02/02/2016 - 11:03am

Greenstone has introduced its authorized generic of the overactive bladder treatment. 

02/01/2016 - 12:00pm

Building on the momentum of last year’s launch of the first U.S. biosimilar, the Biosimilars Forum is looking to educate about and increase access to biosimilars. 

02/01/2016 - 11:33am

Though the drug has met the FDA’s quality, safety and efficacy standards, it won't receive final approval until an ongoing patent infringement proceeding is dealt with. 

02/01/2016 - 11:22am
The Chicago Tribune is reporting that pharmacy benefit manager Express Scripts has opted to block reimbursements for Valeant Pharmaceuticals’ Glumetza once the generic is launched on Feb. 1. According to GoodRx, the drug currently costs about $1,500 for a 30-day supply. “Recent agreements Valeant has signed with retail pharmacies now potentially encourage the pharmacies to bypass the more affordable generic,” Express Scripts said. “To protect our clients and patients from wasteful, unnecessary drug spend, Express Scripts will exclude Glumetza.” (Chicago Tribune)
02/01/2016 - 9:28am

Vfend is indicated to treat fungal infections in adults and children 12 years of age and older.